Elizabeth Masson-Hurlburt
Förmögenhet: 2 M $ per 2026-07-31
Förmögenhet: 2 M $ per 2026-07-31
Elizabeth Masson-Hurlburt is currently Chief Operating & Commercial Officer at CorMedix, Inc., a position starting in 2026.
Formerly, Ms. Masson-Hurlburt was Vice President-Clinical Operations at Gemphire Therapeutics, Inc. from 2016 to 2018.
Education includes an undergraduate degree from Bay Path College and a graduate degree from Western Governors University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
CORMEDIX INC. 0,36 % | 2026-02-04 | 278 539 ( 0,36 % ) | 2 M $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| CORMEDIX INC. | Verksamhetschef | - |
| Företag | Position | Slut |
|---|---|---|
| METAVIA INC. | Teknisk/Vetenskaplig/F&U Direktör | 2018-03-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 4 |
|---|---|
CorMedix, Inc.
CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases | Health Technology |
Bay Path College
Bay Path College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Governors University
Western Governors University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemphire Therapeutics, Inc.
Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for the treatment of Dyslipidemia | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån